Connect your AI

DENTSPLY SIRONA XRAY Debt Issuance Costs

Debt Issuance Costs at other companies

NovantaNOVT

$1.29M—

Zimmer Biomet HoldingsZBH

$0-100%

Amentum HoldingsAMTM

$0-100%

Other financials

Income statement

Revenue$880.0M+0.1%

Gross profit$427.0M-8.4%

Operating income-$35.0M-156%

Net income-$10.0M-150%

EPS (diluted)-$0.05-150%

Balance sheet

Cash & equivalents$190.0M-52.3%

Total debt$2.3B-3.8%

Total equity$1.3B-34.4%

Total assets$5.2B-13.6%

Cash flow

Operating cash flow$40.0M+471%

CapEx$52.0M+174%

Free cash flow-$12.0M0.0%

Valuation

Market cap$2.11B-22.1%

Profitability

Gross margin48.9%-2.6pp

Operating margin-14.1%-3.9pp

Net margin-17.1%-3.9pp

FCF margin2.8%-4.6pp

Returns & leverage

Return on equity-37.7%+4.0pp

Debt / equity1.8×+0.6×

Current ratio1.5×+0.4×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfFinancingCosts.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is DENTSPLY SIRONA's debt issuance costs?: DENTSPLY SIRONA (XRAY) reported debt issuance costs of $0 in Q1 2026.
How has DENTSPLY SIRONA's debt issuance costs changed year-over-year?: DENTSPLY SIRONA's debt issuance costs decreased by 100.0% year-over-year, from $3M to $0.
What does debt issuance costs mean?: Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.